Cited by 330Pancreatic function and diabetesDiabetes and associated disordersSingle-cell and spatial transcriptomics

Novel Observations From Next-Generation RNA Sequencing of Highly Purified Human Adult and Fetal Islet Cell Subsets

Open access
Blodgett, David M., Nowosielska, Anetta, Afik, Shaked, Pechhold, Susanne, Cura, Anthony J., Kennedy, Norman J., Kim, Soyoung, Kucukural, Alper +6 more·2015·Diabetes

Abstract

Understanding distinct gene expression patterns of normal adult and developing fetal human pancreatic α- and β-cells is crucial for developing stem cell therapies, islet regeneration strategies, and therapies designed to increase β-cell function in patients with diabetes (type 1 or 2). Toward that end, we have developed methods to highly purify α-, β-, and δ-cells from human fetal and adult pancreata by intracellular staining for the cell-specific hormone content, sorting the subpopulations by flow cytometry, and, using next-generation RNA sequencing, we report the detailed transcriptomes of fetal and adult α- and β-cells. We observed that human islet composition was not influenced by age, sex, or BMI, and transcripts for inflammatory gene products were noted in fetal β-cells. In addition, within highly purified adult glucagon-expressing α-cells, we observed surprisingly high insulin mRNA expression, but not insulin protein expression. This transcriptome analysis from highly purified islet α- and β-cell subsets from fetal and adult pancreata offers clear implications for strategies that seek to increase insulin expression in type 1 and type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db15-0039

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IAPP (amylin) is expressed at levels 1% and 10% of that of insulin in human and mouse β-cells, respectively.

    “IAPP (amylin) is expressed at levels 1% and 10% of that of insulin in human (68, 475) and mouse β-cells, respectively (Appendix Figure 1A).”

    From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [68]

    The Results section, “Established and Enriched Transcripts in Highly Purified α- and β-Cell Populations” (page unavailable), identifies IAPP and INS as robustly expressed human β-cell genes. It does not give a 1% IAPP-to-insulin expression ratio. The cited paper also does not establish the mouse β-cell ratio; in the citing sentence, that portion is attached to an appendix figure rather than this citation. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • The Na-K ATPase of both mouse and human β-cells is predominantly composed of α1-, β1- and β3-subunits.

    “A tetrameric complex of two α- and two β-subunits, the Na-K ATPase of both mouse and human β-cells is predominantly composed of α1-, β1- and β3-subunits (56, 68).”

    From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [68]

    The Results section on enriched α- and β-cell transcripts lists several β-cell genes but does not discuss Na-K ATPase subunits. Searches of our copy for Na-K ATPase, ATPase, ATP1A1, ATP1B1, and ATP1B3 found no passage establishing that α1, β1, and β3 predominate in human or mouse β-cells. (LLM, conf=0.75)

    Experimental — accuracy not yet measured
  • In contrast to mouse β-cells, the delayed rectifying K+ current in human β-cells is carried principally by Kv2.2 (KCNB2) and Kv1.6 (KCNA6) channels.

    “In contrast to mouse β-cells, the delayed rectifying K+ current in human β-cells is carried principally by Kv2.2 (KCNB2) and Kv1.6 (KCNA6) channels (Appendix Figure 5A), which are expressed at high levels in the human β-cell and encode inactivating TEA-sensitive voltage-gated K+ channels (68, 475).”

    From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [68]

    The Results section on enriched transcripts reports β-cell expression of KCNQ2, but does not address Kv2.2 (KCNB2) or Kv1.6 (KCNA6). Searches for both genes and for delayed-rectifier currents and TEA sensitivity found no passage establishing which channels principally carry the human β-cell current or comparing it with mouse β-cells. Page numbers were not available in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Human β-cells mainly express SCN8A (Nav1.6), accounting for 40% of Na+ channel transcripts, with the remainder being SCN9A (Nav1.7), SCN3A (Nav1.3) and SCN2A (Nav1.2).

    “Whereas mouse β-cells mainly express Scn9a (Nav1.7), SCN8A (Nav1.6) accounts for 40% of Na+ channel transcripts in human β-cells (68, 475) with the remainder being SCN9A (Nav1.7), SCN3A (Nav1.3) and SCN2A (Nav1.2) (see Appendix Figure 4).”

    From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [68]

    The Results section on enriched α- and β-cell transcripts reports β-cell gene expression but does not give the claimed sodium-channel breakdown. Searches for SCN8A, Nav1.6, and the 40% figure found no passage in our copy stating the proportions or identifying SCN9A, SCN3A, and SCN2A as the remainder; page numbers were not available. (LLM, conf=0.72)

    Experimental — accuracy not yet measured
  • Like their mouse counterparts, human β-cells predominantly express SK3 (KCNN3), with other SKs being expressed at 10-fold lower levels.

    “Like their mouse counterparts, human β-cells predominantly express SK3 (KCNN3) with other SKs being expressed at 10-fold lower levels (68, 475).”

    From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [68]

    The Results section on enriched α- and β-cell transcripts names KCNQ2 and KCND3, but does not report KCNN3 or compare expression of SK channels. Searches of our copy for KCNN3, SK3, and the claimed 10-fold difference found no passage addressing that comparison. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 42 · Cited by 330

Research works printed but not linked: 35

  1. [1]Danaei G, Finucane MM, Lu Y,.; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011; 378: 31– 40 21705069
  2. [3]Roglic G, Unwin N, Bennett PH,. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005; 28: 2130– 2135 16123478
  3. [4]van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011; 91: 79– 118 21248163
  4. [6]Cnop M, Abdulkarim B, Bottu G,. RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate. Diabetes 2014; 63: 1978– 1993 24379348
  5. [7]Marselli L, Thorne J, Ahn YB,. Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 2008; 93: 1046– 1053 18073315 PMC2266961
  6. [8]Nica AC, Ongen H, Irminger JC,. Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res 2013; 23: 1554– 1562 23716500 PMC3759730
  7. [9]Dorrell C, Abraham SL, Lanxon-Cookson KM, Canaday PS, Streeter PR, Grompe M. Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers. Stem Cell Res (Amst) 2008; 1: 183– 194 19383399
  8. [10]Pechhold S, Stouffer M, Walker G,. Transcriptional analysis of intracytoplasmically stained, FACS-purified cells by high-throughput, quantitative nuclease protection. Nat Biotechnol 2009; 27: 1038– 1042 19838197 PMC4638177
  9. [11]Hrvatin S, Deng F, O’Donnell CW, Gifford DK, Melton DA. MARIS: method for analyzing RNA following intracellular sorting. PLoS ONE 2014; 9: e89459 24594682 PMC3940959
  10. [13]Bramswig NC, Everett LJ, Schug J,. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest 2013; 123: 1275– 1284 23434589 PMC3582140
  11. [14]Mezza T, Muscogiuri G, Sorice GP,. Insulin resistance alters islet morphology in nondiabetic humans. Diabetes 2014; 63: 994– 1007 24215793 PMC3931397
  12. [15]Yang YP, Thorel F, Boyer DF, Herrera PL, Wright CV. Context-specific α-to-β-cell reprogramming by forced Pdx1 expression. Genes Dev 2011; 25: 1680– 1685 21852533 PMC3165933
  13. [16]Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9: 357– 359 22388286 PMC3322381
  14. [17]Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011; 12: 323 21816040 PMC3163565
  15. [18]Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 2012; 28: 882– 883 22257669 PMC3307112
  16. [19]Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics 2010; 11: 367 20598126 PMC2912887
  17. [20]Kim A, Miller K, Jo J, Kilimnik G, Wojcik P, Hara M. Islet architecture: a comparative study. Islets 2009; 1: 129– 136 20606719 PMC2894473
  18. [21]Pruitt KD, Brown GR, Hiatt SM,. RefSeq: an update on mammalian reference sequences. Nucleic Acids Res 2014; 42: D756– D763 24259432 PMC3965018
  19. [22]Cano DA, Soria B, Martín F, Rojas A. Transcriptional control of mammalian pancreas organogenesis. Cell Mol Life Sci 2014; 71: 2383– 2402 24221136 PMC11113897
  20. [23]Croce K, Gao H, Wang Y,. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009; 120: 427– 436 19620505 PMC3070397
  21. [24]Barrett JC, Clayton DG, Concannon P,.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703– 707 19430480 PMC2889014
  22. [25]Morris AP, Voight BF, Teslovich TM,.; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network–Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012; 44: 981– 990 22885922 PMC3442244
  23. [26]Jain P, Vig S, Datta M,. Systems biology approach reveals genome to phenome correlation in type 2 diabetes. PLoS One 2013; 8: e53522 23308243 PMC3538588
  24. [28]Elbein SC, Gamazon ER, Das SK, Rasouli N, Kern PA, Cox NJ. Genetic risk factors for type 2 diabetes: a trans-regulatory genetic architecture? Am J Hum Genet 2012; 91: 466– 477 22958899 PMC3512001
  25. [29]Pullen TJ, Rutter GA. When less is more: the forbidden fruits of gene repression in the adult β-cell. Diabetes Obes Metab 2013; 15: 503– 512 23121289
  26. [30]Brunet JP, Tamayo P, Golub TR, Mesirov JP. Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci U S A 2004; 101: 4164– 4169 15016911 PMC384712
  27. [32]Collombat P, Mansouri A, Hecksher-Sorensen J,. Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev 2003; 17: 2591– 2603 14561778 PMC218152
  28. [33]Dhawan S, Georgia S, Tschen SI, Fan G, Bhushan A. Pancreatic β cell identity is maintained by DNA methylation-mediated repression of Arx. Dev Cell 2011; 20: 419– 429 21497756 PMC3086024
  29. [34]Spijker HS, Ravelli RB, Mommaas-Kienhuis AM,. Conversion of mature human β-cells into glucagon-producing α-cells. Diabetes 2013; 62: 2471– 2480 23569174 PMC3712074
  30. [35]Petri A, Ahnfelt-Rønne J, Frederiksen KS,. The effect of neurogenin3 deficiency on pancreatic gene expression in embryonic mice. J Mol Endocrinol 2006; 37: 301– 316 17032746
  31. [36]Kang HS, Kim YS, ZeRuth G,. Transcription factor Glis3, a novel critical player in the regulation of pancreatic beta-cell development and insulin gene expression. Mol Cell Biol 2009; 29: 6366– 6379 19805515 PMC2786880
  32. [37]Nogueira TC, Paula FM, Villate O,. GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim. PLoS Genet 2013; 9: e1003532 23737756 PMC3667755
  33. [38]Johannesson M, Ståhlberg A, Ameri J, Sand FW, Norrman K, Semb H. FGF4 and retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a time- and concentration-dependent manner. PLoS One 2009; 4: e4794 19277121 PMC2651644
  34. [39]Katsuta H, Akashi T, Katsuta R,. Single pancreatic beta cells co-express multiple islet hormone genes in mice. Diabetologia 2010; 53: 128– 138 19851748 PMC2789931
  35. [40]Newell EW, Davis MM. Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells. Nat Biotechnol 2014; 32: 149– 157 24441473 PMC4001742

Authors
Blodgett, D. M., Nowosielska, A., Afik, S., Pechhold, S., Cura, A. J., Kennedy, N. J., Kim, S., Kucukural, A., Davis, R. J., Kent, S. C., Greiner, D. L., Garber, M. G., Harlan, D. M., & diIorio, P.
Affiliations
  • University of Massachusetts Chan Medical School (US)
  • Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA
  • Howard Hughes Medical Institute (US)
Corresponding author
Harlan, David M.
Venue
Diabetes
Published
2015-04-30
Volume
64
Issue
9
Pages
3172-3181
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2103920106
Cited by
330
References
42
Citations by year
2026: 11 · 2025: 21 · 2024: 22 · 2023: 40 · 2022: 30 · 2021: 42 · 2020: 32 · 2019: 30 · 2018: 36 · 2017: 36 · 2016: 23 · 2015: 5
FWCI
33.56
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK089572, UC4 DK104218)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
pancreatic islet cells, alpha cells, pancreatic beta cells, delta cells, fetal pancreas, adult pancreas, cell purification, transcriptome, glucagon, insulin mRNA expression, inflammatory gene expression, islet regeneration, stem cell therapy, type 1 diabetes, type 2 diabetes
MeSH terms
Adolescent, Adult, Child, Preschool, Female, Fetus, Humans, Islets of Langerhans, Male, Middle Aged, Pregnancy, Pregnancy Trimester, Second, RNA, Sequence Analysis, RNA, Gene Expression Regulation, Developmental, Somatostatin-Secreting Cells, Gene Expression Profiling, Glucagon-Secreting Cells, Insulin-Secreting Cells, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review